Hippocampal perfusion predicts impending neurodegeneration in REM sleep behavior disorder

Neurology

Volumn 79, Issue 24, 2012, Pages 2302-2306

  Dang Vu, Thien Thanh ^a,b,c,d   Gagnon, Jean François ^a,e   Vendette, Mélanie ^a   Soucy, Jean Paul ^f,g   Postuma, Ronald B ^a,h   Montplaisir, Jacques ^a,i  

^a HÔPITAL DU SACRÉ COEUR DE MONTRÉAL   (Canada)

^b Concordia University ^*  (Canada)

^c UNIVERSITY OF LIÈGE   (Belgium)

^d UNIVERSITY OF LIÈGE   (Belgium)

^e UNIVERSITÉ DU QUÉBEC À MONTRÉAL   (Canada)

^f MCGILL UNIVERSITY   (Canada)

^g CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^h MONTREAL GENERAL HOSPITAL   (Canada)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYLENE CYSTEINATE DIMER TC 99M; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ARTICLE; BRAIN BLOOD FLOW; BRAIN PERFUSION; CLINICAL ARTICLE; COLOR VISION; DIFFUSE LEWY BODY DISEASE; FOLLOW UP; HIPPOCAMPAL PERFUSION; HUMAN; MOTOR PERFORMANCE; NERVE DEGENERATION; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; REM SLEEP; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SLEEP DISORDER; SMELLING; WAKEFULNESS;

EID: 84871285691     PISSN: 00283878     EISSN: 1526632X     Source Type: Journal    
DOI: 10.1212/WNL.0b013e318278b658     Document Type: Article

References (10)

1. Iranzo A, Molinuevo JL, Santamaria J, et al. Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5:572-577.
2. Postuma RB, Gagnon JF, Vendette M, Desjardins C, Montplaisir JY. Olfaction and color vision identify impending neurodegeneration in rapid eye movement sleep behavior disorder. Ann Neurol 2011;69:811-818.
3. Iranzo A, Lomena F, Stockner H, et al. Decreased striatal dopamine transporter uptake and substantia nigra hyperechogenicity as risk markers of synucleinopathy in patients with idiopathic rapid-eye-movement sleep behaviour disorder: a prospective study. Lancet Neurol 2010;9:1070-1077.
4. Vendette M, Gagnon JF, Soucy JP, et al. Brain perfusion and markers of neurodegeneration in rapid eye movement sleep behavior disorder. Mov Disord 2011;26:1717-1724.
5. Cistaro A, Valentini MC, Chio A, et al. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset. Eur J Nucl Med Mol Imaging 2012;39:251-259.
6. Scherfler C, Frauscher B, Schocke M, et al. White and gray matter abnormalities in idiopathic rapid eye movement sleep behavior disorder: a diffusion-Tensor imaging and voxel-based morphometry study. Ann Neurol 2011;69:400-407.
7. Postuma RB, Lang AE, Gagnon JF, Pelletier A, Montplaisir JY. How does parkinsonism start Prodromal parkinsonism motor changes in idiopathic REM sleep behaviour disorder. Brain 2012;135:1860-1870.
8. Imon Y, Matsuda H, Ogawa M, Kogure D, Sunohara N. SPECT image analysis using statistical parametric mapping in patients with Parkinson's disease. J Nucl Med 1999;40: 1583-1589.
9. Boeve BF, Silber MH, Saper CB, et al. Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease. Brain 2007;130:2770-2788.
10. Bohnen NI, Muller ML, Kotagal V, et al. Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain 2010;133:1747-1754.